Axcess Instruments offers a scalable business model, clinical traction, and a protected IP portfolio.

Backed by Patents.
Ready for Investment.

Axcess Instruments business model

Axcess Instruments is poised for scalable growth through a hybrid revenue model that includes both direct sales and recurring revenue. Our single-use disposable surgical device is priced competitively within the laparoscopic market, with projected revenue generation beginning in Year 2 and profitability by Year 3. The AxcessPort™ saves time and cost per procedure by eliminating the need for reprocessing, positioning it as a compelling solution for value-based healthcare systems.

Designed as a plug-and-play platform, the AxcessPort requires minimal training and seamlessly integrates into existing hospital, outpatient, and ambulatory surgery center workflows. This ease of adoption accelerates clinical uptake and positions Axcess Instruments for rapid market penetration. In the future, the AxcessPort’s embedded data capture and AI capabilities offer a path to develop a SaaS extension—unlocking further long-term value through advanced analytics and AI-powered surgical insights.

Our Competitive Advantage

While legacy laparoscopic systems rely on bulky equipment, limited resolution, and high-maintenance processes, the AxcessPort™ delivers a next-generation solution engineered for speed, simplicity, and surgical clarity. By combining six key functions—including AI-enhanced 4K imaging, in-situ lens cleaning, and LED lighting—into a single, palm-sized, disposable device, Axcess Instruments sets a new standard for minimally invasive surgery.

Unlike traditional laparoscopes that require cleaning, calibration, and expensive infrastructure, the AxcessPort is a true plug-and-play tool: surgeon-friendly, facility-flexible, and economically efficient. With no moving parts and no reprocessing required, our platform enables faster procedures, shorter turnover times, and greater consistency—all at a cost that supports both hospital efficiency and long-term scalability. When compared head-to-head, the AxcessPort delivers superior value across every dimension: usability, safety, cost, and performance.

Investment opportunity

  • A growing and aging USA population supports the annual laparoscopic market of $4.4 billion with a projected 5-8% annual growth rate. 750,000-1,000,000 gallbladder surgeries are performed each year which provide a strong foundation to support the AxcessPort™.

  • Any surgery lasting 90 minutes or less gives a competitive advantage for using the AxcessPort™ as it facilitates all features of MIS. It is easy to understand, setup, insert, steer and use. Preparation of the room for the next surgery is simplified. The operating team benefits from each of these features.

  • The Axcess Instruments team has members who have led successful exits with S&P 500 companies.

  • We are currently looking for investors to support our FDA Approval process. We already have partners for our manufacturing and reliable market readiness and intellectual property development.

Investor Inquiries

Interested in learning more about the AxcessPort™, our patents, financials, or clinical progress? We welcome qualified investors and strategic partners to reach out for access to our due diligence materials, pitch deck, or a one-on-one conversation with our leadership team.

Please fill out the short form, and a member of our team will follow up with next steps. You may also contact Dr. Michael Norton directly at mnorton@axcessinstruments.com